Negative Impact of Coronavirus Disease 2019 Pandemic on Gastric Cancer Care in Japan: A Tokushukai Real‐World Data Project 08 ( <scp>TREAD</scp> 08)
This nationwide, real-world study provides robust evidence that COVID-19 has reduced survival rates for Japanese patients with gastric cancer by disrupting diagnosis and treatment.
Authors
- Yoshiaki Fujimura
- Rai Shimoyama (ORCID: https://orcid.org/0000-0001-8601-0442)
- Masataka Taguri (ORCID: https://orcid.org/0000-0001-8902-0056)
- Yoshinori Imamura (ORCID: https://orcid.org/0000-0002-5202-531X)
- Kiyoaki Uryu (ORCID: https://orcid.org/0009-0008-6068-1385)
- Megumi Shiragami
- Maki Hayashi (ORCID: https://orcid.org/0000-0002-1704-8049)
- Hironobu Minami (ORCID: https://orcid.org/0000-0001-8630-9145)
- T. Mase (ORCID: https://orcid.org/0009-0003-6071-550X)
- T. Okuda (ORCID: https://orcid.org/0009-0005-1432-6938)
Institutions
- Tokyo Medical University (JP)
- Kyoto University (JP)
- Kobe University Hospital (JP)
- Fukuoka Tokushukai Hospital (JP)
- University of Fukui Hospital (JP)
- University of Tokyo Health Sciences (JP)
- Yao Tokushukai General Hospital (JP)
- Mirai Hospital (JP)
- Shonan Kamakura General Hospital (JP)
- Kobe University (JP)
Publication Details
- Journal
- JGH Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/jgh3.70285
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science